Erytech Pharma S.A. buy tbackenh
Start price
26.09.16
/
50%
€19.25
Target price
27.03.17
€22.00
Performance (%)
-25.71%
End price
27.03.17
€14.30
Summary
This prediction ended on 27.03.17 with a price of €14.30. The price of Erytech Pharma S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.71%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - |
| iShares Core DAX® | 0,19 % | -1,22 % | 8,84 % | 58,52 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % | -1,14 % | 82,23 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % | 27,58 % | 65,21 % |
| iShares S&P 500 | -1,01 % | -3,40 % | -0,22 % | 56,66 % |
Comments by tbackenh for this prediction
In the thread Erytech Pharma S.A. diskutieren
Erytech Pharma S.A.
Phase 2 eines Bauchspeicheldrüsenkrebsmedikamentes erfolgreich abgeschlossen, könnte 2017 richtig abgehen.
(Laufzeit überschritten)
Stopped prediction by tbackenh for Erytech Pharma S.A.
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€28.20
31.03.17
31.03.17
€32.00
02.10.17
02.10.17
-17.59%
02.10.17
02.10.17
